Learn more at LeadIQ.com

Insights

Gathering insights about Septerna…

Similar companies to Septerna

Septerna Tech Stack

Septerna uses 8 technology products and services including Docker, WordPress, MySQL, and more. Explore Septerna's tech stack below.

Docker
Containerization
WordPress
Content Management System
MySQL
Database
Shopify
E-commerce
Okta
Identity Verification
Google Cloud
Infrastructure As A Service
Vue.js
Javascript Frameworks
Python
Programming Languages

Media & News

Septerna Inc. is planning to go public.
In addition, Septerna has announced plans for an upcoming IPO, aiming to fund the continued development of SEP-786 and its pipeline of GPCR-targeted therapies.
Oct 13, 2024 | cryoduck.com
Septerna Inc. is planning to go public.
South San Francisco-based Septerna Inc. filed an S-1 with the U.S. SEC to conduct an IPO on Nasdaq about two years and eight months after launching operations with a $100 million series A led by Third Rock Ventures.
Oct 03, 2024 | www.bioworld.com
Septerna Inc. hires Kim as Chief Medical Officer.
Dr. Kim joins Septerna from Design Therapeutics, where he served as Chief Medical Officer and led the clinical advancement of the company's pipeline of small molecule genomic therapeutics.
Sep 25, 2024 | www.businesswire.com
Septerna Inc. hires Shalini Sharp as board of directors.
Biotechnology firm Septerna has welcomed two industry stalwarts, Bernard Coulie, M.D., Ph.D., and Shalini Sharp, MBA, to its board of directors.
Feb 05, 2024 | bnnbreaking.com
Septerna Inc. hires Bernard Coulie as board of directors.
Biotechnology firm Septerna has welcomed two industry stalwarts, Bernard Coulie, M.D., Ph.D., and Shalini Sharp, MBA, to its board of directors.
Feb 05, 2024 | bnnbreaking.com
Septerna Inc. receives financing of $47.5M in funding.
Septerna, a biotech company, has secured an additional $47.5 million in funding through a licensing agreement with Vertex, a prominent cystic fibrosis drug manufacturer.
Sep 12, 2023 | pharmtales.com
Septerna Inc. is developing gpcr-targeting drugs for rare diseases.
Vertex partners with Septerna to develop gpcr-targeting drugs for rare diseases.
Sep 12, 2023 | pharmtales.com

Septerna's Email Address Formats

Septerna uses at least 1 format(s):

Septerna Email Formats	Example	Percentage
FLast@septerna.com	JDoe@septerna.com	97%
FMiddleLast@septerna.com	JMichaelDoe@septerna.com	1%
FiLast@septerna.com	JoDoe@septerna.com	1%
FL@septerna.com	JD@septerna.com	1%

Frequently Asked Questions

Where is Septerna's headquarters located?

Septerna's main headquarters is located at 250 E Grand Ave 65 South San Francisco, California 94080 US. The company has employees across 2 continents, including North AmericaAsia.

What is Septerna's stock symbol?

Septerna is a publicly traded company; the company's stock symbol is SEPN.

What is Septerna's official website and social media links?

Septerna's official website is septerna.com and has social profiles on LinkedIn.

How much revenue does Septerna generate?

As of August 2024, Septerna's annual revenue reached $15M.

What is Septerna's SIC code NAICS code?

Septerna's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Septerna have currently?

As of August 2024, Septerna has approximately 79 employees across 2 continents, including North AmericaAsia. Key team members include Chief Operating Officer: L. B.Chief People Officer: S. S.Vice President Clinpharm And Dmpk: U. H.. Explore Septerna's employee directory with LeadIQ.

What industry does Septerna belong to?

Septerna operates in the Biotechnology Research industry.

What technology does Septerna use?

Septerna's tech stack includes DockerWordPressMySQLShopifyOktaGoogle CloudVue.jsPython.

What is Septerna's email format?

Septerna's email format typically follows the pattern of . Find more Septerna email formats with LeadIQ.

How much funding has Septerna raised to date?

As of August 2024, Septerna has raised $150M in funding. The last funding round occurred on Jul 11, 2023 for $150M.

Septerna

Septerna

Biotechnology ResearchCalifornia, United States51-200 Employees

Septerna is on a mission to make the promise of future GPCR medicines a reality for patients. Combining the latest advances in biochemical, structural and computational drug discovery approaches, we have built an industrialized platform to precisely control and modulate GPCR biology and pharmacology to discover and develop new high-impact medicines. With our Native Complex™ platform, we are opening a new frontier in GPCR small molecule discovery technologies to expand the druggable GPCR landscape. 

We are always looking for talented scientists, drug hunters, and business professionals to join our mission to launch a new era of GPCR medicines. If you’re passionate about innovation, energized by teamwork, and fueled by the desire to change patient lives, join us and become a part of the Septerna story!

Company Overview

Headquarters: 250 E Grand Ave 65 South San Francisco, California 94080 US
Website: septerna.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: SEPN
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 51-200

Media & News

Funding & Financials

$150M
Septerna has raised a total of $150M of funding over 2 rounds. Their latest funding round was raised on Jul 11, 2023 in the amount of $150M.
$10M$50M
Septerna's revenue is in the range of $10M$50M

Funding & Financials

$150M
Septerna has raised a total of $150M of funding over 2 rounds. Their latest funding round was raised on Jul 11, 2023 in the amount of $150M.
$10M$50M
Septerna's revenue is in the range of $10M$50M

Company Leadership

L. B.
Chief Operating Officer
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. S.
Chief People Officer
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
U. H.
Vice President Clinpharm And Dmpk
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. E.
Head Of Talent Acquisition
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. L.
Head Of Program And Portfolio Management
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

M. V.
Vice President, Medicinal Chemistry
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. M.
Vice President, Disease Biology And Translational Sciences
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. H.
Vp, Technology
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
U. H.
Vice President Clinpharm And Dmpk
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. X.
Vp, Finance And Business Operations
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Septerna and Millions of Other Companies
Sign up for full access to Septerna information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.